BioLineRx Ltd. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Modi In
SEC filing record 1 source field available
Fiscal year end
31 December
BioLineRx Ltd. has filed 612 SEC EDGAR filings since 24 Sep 2010

SEC filing history

Showing 126-150 of 612 matching filings.

Per page
25
Current page
6
6-K File 001-35223

6-K

Filing date
27 Oct 2021
Reporting date
27 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
13 Oct 2021
Reporting date
13 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-35223

CT ORDER filing

Filing date
21 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
03 Sep 2021
Reporting date
03 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-251857

424B5

Filing date
03 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
26 May 2021
Reporting date
26 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
04 May 2021
Reporting date
04 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
15 Apr 2021
Reporting date
15 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
05 Apr 2021
Reporting date
05 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
26 Feb 2021
Reporting date
26 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-239485

EFFECT filing

Filing date
24 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-239485

POS AM

Filing date
23 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
23 Feb 2021
Reporting date
23 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-86614

SC 13G/A

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-86614

AMENDMENT TO SCHEDULE 13G

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-86614

BIOLINERX LTD.

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-86614

AMENDMENT NO. 1 TO SCHEDULE 13G

Filing date
29 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
22 Jan 2021
Reporting date
22 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
21 Jan 2021
Reporting date
21 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-251857

424B5

Filing date
21 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-251857

FWP

Filing date
20 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-251857

FWP

Filing date
19 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-251857

424B5

Filing date
19 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .